首页> 美国卫生研究院文献>Radiation Oncology (London England) >Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial

【2h】

Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial

机译：评估被动散射质子治疗对III期非小细胞肺癌局部复发的稳健性：II期试验的二级分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundWe assessed the robustness of passive scattering proton therapy (PSPT) plans for patients in a phase II trial of PSPT for stage III non-small cell lung cancer (NSCLC) by using the worst-case scenario method, and compared the worst-case dose distributions with the appearance of locally recurrent lesions.

机译：背景我们在PSPT的II期临床试验中通过最坏情况方案方法评估了患者接受被动散射质子治疗（PSPT）计划对III期非小细胞肺癌（NSCLC）患者的鲁棒性，并比较了最坏情况剂量分布与局部复发病灶的出现有关。

著录项

期刊名称 Radiation Oncology (London England)
作者
Zhengfei Zhu; Wei Liu; Michael Gillin; Daniel R Gomez; Ritsuko Komaki; James D Cox; Radhe Mohan; Joe Y Chang;
展开▼
作者单位

展开▼
年(卷),期 2014(9),-1
年度 2014
页码 108
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;放射医学;影像诊断学;
关键词
Non-small cell lung cancer Proton therapy Passive scattering proton therapy Robustness analysis Worst-case scenario method;

机译：非小细胞肺癌;质子治疗;被动散射质子治疗;鲁棒性分析;最坏情况法;

相似文献

外文文献
中文文献
专利

1. Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial [J] . Zhengfei Zhu, Wei Liu, Michael Gillin, Radiation oncology . 2014,第1期

机译：评估被动散射质子治疗对III期非小细胞肺癌局部复发的稳健性：II期试验的二级分析
2. Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial [J] . Zhengfei Zhu, Wei Liu, Michael Gillin, Radiation oncology . 2014,第1期

机译：评估III期非小细胞肺癌局部复发的被动散射质子疗法的鲁棒性：II期试验的二次分析
3. 21LBA Assessing the value of preoperative chemotherapy in early-stage non-small cell lung cancer: mature data and prognostic factors analysis of a Phase III randomized trial of surgery alone vs preoperative Paclitaxel/Carboplatin (PC) vs postoperative PC. Final NATCH data. A Spanish Lung Cancer Group Trial [J] . B.Massuti, J.M.Sanchez, G.Alonso, European Journal of Cancer Supplements . 2009,第3期

机译：21LBA评估术前早期非小细胞肺癌化疗的价值：一项单独的手术，术前紫杉醇/卡铂（PC）与术后PC的III期随机试验的成熟数据和预后因素分析。最终的NATCH数据。西班牙肺癌小组审判
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. A Study of Erlotinib Monotherapy and in Combination with Pembrolizumab in Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [D] . Liu, Qiong. 2021

机译：Erlotinib单疗法和蛋白质在先前未处理阶段I-IIIA非小细胞肺癌中的研究
6. Intensity-Modulated Proton Therapy Reduces Normal Tissue Doses Compared with Intensity-Modulated Radiation Therapy or Passive Scattering Proton Therapy and Enables Individualized Radical Radiotherapy for Extensive Stage IIIB Non-Small Cell Lung Cancer: A Virtual Clinical Study [O] . Xiaodong Zhang, Yupeng Li, Xiaoning Pan, -1

机译：与强度调制的放射治疗或被动散射质子疗法相比强度调制的质子疗法减少了正常组织剂量并使得能够进行各种阶段IIIB非小细胞肺癌的个体化的自由基放射治疗：虚拟临床研究
7. Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial [O] . 2014

机译：评估被动散射质子治疗对III期非小细胞肺癌局部复发的稳健性：II期试验的二级分析

Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial

摘要

著录项

相似文献

相关主题

期刊订阅